PAZ320: Phase IIb started

By WIR Staff | Nov 18, 2013 | 8:00 AM GMT

Boston Therapeutics began a double-blind, placebo-controlled, French

Read the full 74 word article

How to gain access

Continue reading with a
two-week free trial.